KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Medpace Holdings (MEDP) Shares Issued (2016 - 2026)

Medpace Holdings filings provide 11 years of Shares Issued readings, the most recent being $12.7 million for Q1 2026.

  • On a quarterly basis, Shares Issued fell 51.15% to $12.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $43.7 million, a 28.14% increase, with the full-year FY2025 number at $57.0 million, up 259.45% from a year prior.
  • Shares Issued hit $12.7 million in Q1 2026 for Medpace Holdings, down from $22.7 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $25.9 million in Q1 2025 to a low of $351000.0 in Q2 2025.
  • Median Shares Issued over the past 5 years was $5.7 million (2023), compared with a mean of $7.0 million.
  • Biggest five-year swings in Shares Issued: crashed 82.24% in 2023 and later skyrocketed 1706.76% in 2025.
  • Medpace Holdings' Shares Issued stood at $5.8 million in 2022, then crashed by 73.56% to $1.5 million in 2023, then dropped by 17.4% to $1.3 million in 2024, then skyrocketed by 1706.76% to $22.7 million in 2025, then crashed by 44.26% to $12.7 million in 2026.
  • The last three reported values for Shares Issued were $12.7 million (Q1 2026), $22.7 million (Q4 2025), and $8.0 million (Q3 2025) per Business Quant data.